Studies of GLP-1 discontinuation show that without continued therapy or behavioral structure, most patients regain two-thirds of lost weight within a year
But with the company's main source of growth set to be extinguished, its unclear how it can sustain its lofty valuation, with the stock trading at a price-to-earnings ratio of about 87x
This introduces potential variability in actual peptide content compared to stated concentrations
Its multi-receptor agonism creates a synergistic effect, positioning Retatrutide as a promising agent for managing obesity, type 2 diabetes mellitus, and related metabolic conditions
92 , e13566 (2021)
Because you have less glucose, your bodys blood sugar levels go downand along with excess glucose, an additional 300 calories are excreted per day, leading to a modest amount of weight loss